The Bordeaux Sleepiness Scale (BOSS): a new questionnaire to measure sleep-related driving risk.


Journal

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
ISSN: 1550-9397
Titre abrégé: J Clin Sleep Med
Pays: United States
ID NLM: 101231977

Informations de publication

Date de publication:
01 05 2023
Historique:
pmc-release: 01 05 2024
medline: 3 5 2023
pubmed: 3 2 2023
entrez: 2 2 2023
Statut: ppublish

Résumé

Sleepiness is a well-known risk factor for traffic accidents. Our study presents a new questionnaire, the Bordeaux Sleepiness Scale (BOSS), specifically designed to evaluate sleep-related driving risk in patients with sleep disorders. The BOSS was designed by gathering data on sociodemographics, sleepiness, driving items, and traffic accident exposure (kilometers driven) in the past year of 293 patients followed for sleep disorders at a French sleep clinic. It was then validated on data from a large population-based cohort of 7,296 highway drivers. Its performance was compared to the Epworth sleepiness scale and to self-reported episodes of severe sleepiness at the wheel. Receiver operating characteristic curves were computed. The sensitivity and specificity of the BOSS (cutoff = 3) to predict sleep-related near-misses or accidents was, respectively, 82% and 74%, with an area under the receiver operating characteristic curve of 0.83. In a cohort of patients and a large population-based cohort, the area under the curve of the BOSS was significantly larger than that of the Epworth sleepiness scale ( The BOSS scale combining exposure (kilometers driven) and self-perception of situational sleepiness provides a simple and reliable evaluation of sleep-related driving risk. This short, specific questionnaire should be promoted as a first-line tool to evaluate the risk of traffic accidents in sleepy patients. Philip P, Micoulaud-Franchi J-A, Taillard J, et al. The Bordeaux Sleepiness Scale (BOSS): a new questionnaire to measure sleep-related driving risk.

Identifiants

pubmed: 36727504
pii: jcsm.10470
doi: 10.5664/jcsm.10470
pmc: PMC10152350
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

957-965

Informations de copyright

© 2023 American Academy of Sleep Medicine.

Références

Otolaryngol Head Neck Surg. 2002 Mar;126(3):217-27
pubmed: 11956528
Am J Respir Crit Care Med. 2004 Nov 1;170(9):1014-21
pubmed: 15317672
Eur Respir J. 2002 Dec;20(6):1594-609
pubmed: 12503722
Sci Rep. 2020 Oct 1;10(1):16267
pubmed: 33004829
Sleep. 2007 Mar;30(3):331-42
pubmed: 17425230
Nat Sci Sleep. 2021 Oct 05;13:1737-1746
pubmed: 34675722
Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1407-12
pubmed: 11029353
BMJ. 2001 Apr 7;322(7290):829-30
pubmed: 11290636
J Safety Res. 2018 Jun;65:141-151
pubmed: 29776523
J Clin Med. 2022 Jun 27;11(13):
pubmed: 35806976
Neurology. 2019 Apr 9;92(15):e1754-e1762
pubmed: 30867266
Psychophysiology. 1973 Jul;10(4):431-6
pubmed: 4719486
J Sleep Res. 2015 Jun;24(3):242-53
pubmed: 25581328
Sleep Med Rev. 2020 Jun;51:101275
pubmed: 32169792
Sleep Med. 2014 Jan;15(1):23-6
pubmed: 24286897
Psychiatry Res. 2019 Nov;281:112547
pubmed: 31494450
Sleep. 2021 Nov 12;44(11):
pubmed: 34173829
Lancet Respir Med. 2016 May;4(5):407-18
pubmed: 27304558
Sleep. 2020 Jun 15;43(6):
pubmed: 31993661
Sleep Med. 2010 Dec;11(10):973-9
pubmed: 20961809
Respir Med. 2000 Oct;94(10):971-6
pubmed: 11059950
Sleep Med Clin. 2019 Dec;14(4):407-412
pubmed: 31640868
Sleep Med Rev. 2008 Apr;12(2):129-41
pubmed: 18342261
BMJ. 2002 May 11;324(7346):1125
pubmed: 12003884
Sleep Med Clin. 2019 Dec;14(4):441-451
pubmed: 31640872
Sleep Med Clin. 2021 Sep;16(3):533-543
pubmed: 34325829
Clin Chem. 1993 Apr;39(4):561-77
pubmed: 8472349
Sleep. 2017 Oct 1;40(10):
pubmed: 28958002
Sleep. 1997 Aug;20(8):608-13
pubmed: 9351127
Sleep. 1997 Oct;20(10):835-43
pubmed: 9415942
PLoS One. 2015 Jun 08;10(6):e0129386
pubmed: 26052938
Sleep Med Rev. 2017 Aug;34:70-81
pubmed: 27568340
Int J Neurosci. 1990 May;52(1-2):29-37
pubmed: 2265922
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
J Clin Sleep Med. 2006 Apr 15;2(2):193-200
pubmed: 17557495
J Clin Sleep Med. 2015 Nov 15;11(11):1289-98
pubmed: 26094931
Br J Clin Pharmacol. 2021 Feb;87(2):612-621
pubmed: 32530532
Sleep Med Rev. 2021 Dec;60:101533
pubmed: 34461582
Chronobiol Int. 2010 May;27(3):575-89
pubmed: 20524802

Auteurs

Pierre Philip (P)

Sleep, Addiction and Neuropsychiatry, University of Bordeaux, Bordeaux, France.
CNRS, SANPSY, UMR 6033, Bordeaux, France.
CHU de Bordeaux, Centre Hypersomnies Rares, Bordeaux, France.
INSERM CIC1401, Université de Bordeaux, CHU de Bordeaux, Bordeaux, France.

Jean-Arthur Micoulaud-Franchi (JA)

Sleep, Addiction and Neuropsychiatry, University of Bordeaux, Bordeaux, France.
CNRS, SANPSY, UMR 6033, Bordeaux, France.
CHU de Bordeaux, Centre Hypersomnies Rares, Bordeaux, France.

Jacques Taillard (J)

Sleep, Addiction and Neuropsychiatry, University of Bordeaux, Bordeaux, France.
CNRS, SANPSY, UMR 6033, Bordeaux, France.
CHU de Bordeaux, Centre Hypersomnies Rares, Bordeaux, France.

Julien Coelho (J)

Sleep, Addiction and Neuropsychiatry, University of Bordeaux, Bordeaux, France.
CNRS, SANPSY, UMR 6033, Bordeaux, France.
CHU de Bordeaux, Centre Hypersomnies Rares, Bordeaux, France.

Camille Tisserand (C)

CHU de Bordeaux, Centre Hypersomnies Rares, Bordeaux, France.

Yves Dauvilliers (Y)

Reference National Center for Narcolepsy, Sleep Unit, CHU Montpellier, Montpellier, France.
PSNREC, University of Montpellier, INSERM, Montpellier, France.

Patricia Sagaspe (P)

Sleep, Addiction and Neuropsychiatry, University of Bordeaux, Bordeaux, France.
CNRS, SANPSY, UMR 6033, Bordeaux, France.
CHU de Bordeaux, Centre Hypersomnies Rares, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH